Systemic lupus erythematosus (SLE) : (Record no. 91468)

MARC details
000 -LEADER
fixed length control field 04371cam a2200565 i 4500
001 - CONTROL NUMBER
control field ocn865830589
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128212428.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130816s2013 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2019713832
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
019 ## -
-- 923672973
-- 928194735
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781629480411
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 162948041X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781628089905
Qualifying information hardcover
035 ## - SYSTEM CONTROL NUMBER
System control number 652533
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)865830589
Canceled/invalid control number (OCoLC)923672973
-- (OCoLC)928194735
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Systemic lupus erythematosus (SLE) :
Subtitle prevalence, pathophysiology, and prognosis
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical,
Date of production, publication, distribution, manufacture, or copyright notice [2013]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Immunology and immune system disorders
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): PREVALENCE, PATHOPHYSIOLOGY AND PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): PREVALENCE, PATHOPHYSIOLOGY AND PROGNOSIS; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Illustrated Overview of the Prevalence and Clinical Symptoms of Systemic Lupus Erythematosus; Abstract; Introduction; Epidemiology; Constitutional Symptoms; Manifestations of the Involvement of Specific Organs; Gastrointestinal Disease: Digestive System; Renal Disease: Lupus Nephritis; Ophthalmologic Findings; Conclusion; References.
505 8# - CONTENTS
Contents Chapter 2: The Pathophysiology of Systemic Lupus ErythematosusAbstract; Introduction; Genetic Susceptibility; Environmental Triggers; The Source of Autoantigens in SLE; Sex Hormones and SLE; B- and T-Cell Hyperactivity; Autoantibodies in SLE; Cytokines in SLE; Conclusion; References; Chapter 3: MBL and MBL Genotypes in SLE; Abstract; Introduction; References; Chapter 4: Novel Biological Activitiesof Autoantibodies as the Potential Markers of Systemic Lupus Erythematosus; Abstract; Abbreviations; 1. Introduction; 2. Methods; 3. Results and Discussion; Conclusion; References.
505 8# - CONTENTS
Contents Chapter 5: Cytokines in Systemic Lupus Erythematosus (SLE): Clinical Aspects and PrognosticsAbstract; Introduction; Conclusion; References; Chapter 6: Prognosis in Systemic Lupus Erythematosus; Abstract; Systemic Lupus Erythematosus Development and Cardiovascular Involvement; SLE Improved Survival and Therapies; Regular Treatment for SLE; Conclusion; Grants; References; Chapter 7: Autoantibody-Producing RP105-Negative B Cells in Humans and a Murine Model of Lupus Erythematosus; Abstract; Introduction; Conclusion; References; EDITOR CONTACT INFORMATION; Index.
520 ## - ABSTRACT
Abstract Systemic lupus erythematosus (SLE) is one of the prototypical systemic autoimmune diseases characterized by inflammation, immune complex deposition, and vasculitis. Patients with SLE show various symptoms and clinical images, both constitutional and specific organ symptoms. They include the skin, joints, muscles, kidneys, lungs, nervous system, and blood vessels. Although the etiology of the disease is still unclear, genetic, hormonal, immunologic abnormalities and environmental factors complicatedly play important roles in the pathophysiology in SLE. It is evident that multiple genes show gen.
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050, 082, 650
650 #0 - SUBJECT HEADINGS
Subject term Systemic lupus erythematosus.
700 1# - ADDED PERSONAL NAME
Added personal author Koarada, Syuichi,
Relator term editor of compilation.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Immunology and immune system disorders.
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=652533">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=652533</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 11241699
938 ## -
-- EBSCOhost
-- EBSC
-- 652533
938 ## -
-- ebrary
-- EBRY
-- ebr10784531
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3023281
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=652533 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice